Blaine Templeman

Aduro BioTech, Inc. is a clinical-stage immunotherapy company, which engages in the discovery, development, and commercialization of therapies that transform the treatment of diseases, including cancer. Its technology platforms include STING Pathway Activator, B-select monoclonal antibody, and LADD, or Live, Attenuated, Double-Deleted Listeria monocytogenes. The company's platforms stimulate and/or regulate innate and adaptive immune responses, either as single agents or in combination with conventional therapies like chemotherapy and radiation as well as other novel immunotherapies. Aduro BioTech was founded in 2000 and is headquartered in Berkeley, CA.

Arnold & Porter LLP is engaged in the provision of legal services. It offers transactional, regulatory, and litigation services in the areas of antitrust and competition, appellate and supreme court, attorney liability, bankruptcy and corporate restructuring, compensation and benefits, congressional investigations, consumer product safety, consumer protection and advertising, corporate and securities, derivatives and commodities, financial services, government contracts, intellectual property, international arbitration, international trade, labor and employment, legislative and public policy, litigation, national and homeland security, private client services, product liability litigation, public international law, real estate, and white collar criminal defense. The company was founded by Thurman Wesley Arnold, Paul Aldermandt Porter, and Abraham Fortas in 1946 and is headquartered in Washington, DC.

Sheppard, Mullin, Richter & Hampton LLP provides legal services. It offers legal expertise and counsel to U.S. and international clients in a range of practice areas including antitrust, corporate and securities, entertainment, media and communications, finance, and white collar defense. The company was founded in 1927 and it is headquartered in Los Angeles, CA.

Heller Ehrman LLP provides legal services. It offers litigation, business, and intellectual property services. The company was founded in 1980 and is headquartered in San Francisco, CA.

Cartography Biosciences, Inc. is a biotech company that specializes in developing tumor-selective therapeutics using a unique genomics and computational platform. The company is based in Foster City, CA. The company integrates data from proprietary sample sourcing relationships, a comprehensive reference atlas, and target identification algorithms to identify the cells of interest and the single or pairs of targets that are most specific to the intended target cells. Cartography Biosciences is unlocking the full potential of immunotherapy by discovering and developing therapeutics as precise as their targets. The company was founded by Ansuman Satpathy, Howard Y. Chang, Kevin Parker. Kevin Parker has been the CEO since incorporation.